Outset Medical Inc. Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales

Reuters

05/08

<a href="https://laohu8.com/S/OM">Outset Medical Inc.</a> Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales

Outset Medical Inc. reported its first quarter 2025 financial results, highlighting a revenue increase to $29.8 million, a 6% rise from $28.2 million in the same quarter of 2024. Product revenue reached $21.3 million, showing a 4% growth from $20.4 million in the prior year. The company emphasized the strong progress in its commercial transformation and operational execution. Additionally, Outset reiterated its 2025 revenue guidance, projecting between $115 million and $125 million, with a non-GAAP gross margin expected in the high-30% range. The company also anticipates using less than $50 million in cash for 2025, a reduction from the $103 million used in 2024. CEO Leslie Trigg noted the growth in console placements and utilization-driven recurring revenue, along with the expansion of their installed base in both acute and home hemodialysis settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9446003-en) on May 07, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2533966418"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533966418\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533966418?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-08 04:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533966418","market":"us","top_or_hot":-1,"title":"Outset Medical Inc. Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OM\">Outset Medical Inc.</a> Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Outset Medical Inc. reported its first quarter 2025 financial results, highlighting a revenue increase to $29.8 million, a 6% rise from $28.2 million in the same quarter of 2024. Product revenue reached $21.3 million, showing a 4% growth from $20.4 million in the prior year. The company emphasized the strong progress in its commercial transformation and operational execution. Additionally, Outset reiterated its 2025 revenue guidance, projecting between $115 million and $125 million, with a non-GAAP gross margin expected in the high-30% range. The company also anticipates using less than $50 million in cash for 2025, a reduction from the $103 million used in 2024. CEO Leslie Trigg noted the growth in console placements and utilization-driven recurring revenue, along with the expansion of their installed base in both acute and home hemodialysis settings.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9446003-en) on May 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Outset Medical Inc. Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOutset Medical Inc. Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-08 04:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OM\">Outset Medical Inc.</a> Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Outset Medical Inc. reported its first quarter 2025 financial results, highlighting a revenue increase to $29.8 million, a 6% rise from $28.2 million in the same quarter of 2024. Product revenue reached $21.3 million, showing a 4% growth from $20.4 million in the prior year. The company emphasized the strong progress in its commercial transformation and operational execution. Additionally, Outset reiterated its 2025 revenue guidance, projecting between $115 million and $125 million, with a non-GAAP gross margin expected in the high-30% range. The company also anticipates using less than $50 million in cash for 2025, a reduction from the $103 million used in 2024. CEO Leslie Trigg noted the growth in console placements and utilization-driven recurring revenue, along with the expansion of their installed base in both acute and home hemodialysis settings.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9446003-en) on May 07, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OM","symbol_name":"Outset Medical Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nNDLc6M67t:1","article_id":"2533966418","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533966418","pubTimestamp":1746648177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Outset Medical Inc. reported its first quarter 2025 financial results, highlighting a revenue increase to $29.8 million, a 6% rise from $28.2 million in the same quarter of 2024. Product revenue reached $21.3 million, showing a 4% growth from $20.4 million in the prior year. The company emphasized the strong progress in its commercial transformation and operational execution. Additionally, Outset reiterated its 2025 revenue guidance, projecting between $115 million and $125 million, with a non-GAAP gross margin expected in the high-30% range. The company also anticipates using less than $50 million in cash for 2025, a reduction from the $103 million used in 2024. CEO Leslie Trigg noted the growth in console placements and utilization-driven recurring revenue, along with the expansion of their installed base in both acute and home hemodialysis settings.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"OM":"Outset Medical Inc.","NDAQ":"纳斯达克OMX交易所"},"translate_title":"Outset医疗公司。报告称，在Tablo控制台销售额增长23%的推动下，第一季度收入增长6%，达到2,980万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"OM":0.9},"content_text":"Outset Medical Inc. Reports 6% Increase in Q1 Revenue to $29.8 Million, Driven by 23% Growth in Tablo Console Sales\n    \n\n        Outset Medical Inc. reported its first quarter 2025 financial results, highlighting a revenue increase to $29.8 million, a 6% rise from $28.2 million in the same quarter of 2024. Product revenue reached $21.3 million, showing a 4% growth from $20.4 million in the prior year. The company emphasized the strong progress in its commercial transformation and operational execution. Additionally, Outset reiterated its 2025 revenue guidance, projecting between $115 million and $125 million, with a non-GAAP gross margin expected in the high-30% range. The company also anticipates using less than $50 million in cash for 2025, a reduction from the $103 million used in 2024. CEO Leslie Trigg noted the growth in console placements and utilization-driven recurring revenue, along with the expansion of their installed base in both acute and home hemodialysis settings.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outset Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9446003-en) on May 07, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}